{
  "main_header": {
    "sid": 555664,
    "name": "Bal Pharma",
    "stock_name": "Bal Pharma",
    "full_name": "Bal Pharma Ltd",
    "name_url": "stocks-analysis/bal-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "73.96",
    "chg": -0.61,
    "chgp": "-0.82%",
    "dir": -1,
    "prev_price": "74.57",
    "mcapval": "117.75 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524824,
    "symbol": "BALPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE083D01012",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "3.34 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bal-pharma-555664-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bal Pharma’s Market Assessment Revised Amidst Challenging Financial and Technical Indicators",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-downgraded-to-strong-sell-amid-deteriorating-fundamentals-and-bearish-technicals-3748258",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BalPharma_mojoScore_3748258.png",
        "date": "2025-12-05 10:10:27",
        "description": "Bal Pharma has experienced a revision in its market evaluation, reflecting a more cautious outlook driven by recent financial results, valuation considerations, and technical trends. This shift highlights the complexities facing the pharmaceutical company amid ongoing sector challenges and market pressures."
      },
      {
        "title": "Bal Pharma Stock Falls to 52-Week Low of Rs.73.04 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-stock-falls-to-52-week-low-of-rs7304-amidst-continued-underperformance-3748384",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BalPharma_priceRelatedfactors_3748384.png",
        "date": "2025-12-05 09:53:08",
        "description": "Bal Pharma's shares touched a fresh 52-week low of Rs.73.04 today, marking a significant milestone in the stock's ongoing downward trajectory. This new low reflects continued pressures on the company’s financial performance and market valuation within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Bal Pharma Stock Falls to 52-Week Low of Rs.73.04 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-stock-falls-to-52-week-low-of-rs7304-amidst-continued-underperformance-3748383",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BalPharma_priceRelatedfactors_3748383.png",
        "date": "2025-12-05 09:53:08",
        "description": "Bal Pharma’s shares touched a fresh 52-week low of Rs.73.04 today, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s stock declined by 2.05% during the trading session, underperforming its sector peers and continuing a trend of subdued market performance over the past year."
      },
      {
        "title": "Bal Pharma Stock Falls to 52-Week Low of Rs.73.61 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-stock-falls-to-52-week-low-of-rs7361-amidst-continued-downtrend-3746773",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BalPharma_priceRelatedfactors_3746773.png",
        "date": "2025-12-04 12:43:48",
        "description": "Bal Pharma's shares reached a fresh 52-week low of Rs.73.61 today, marking a continuation of the stock's downward trajectory over recent sessions. The pharmaceutical company’s stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial and operational metrics."
      },
      {
        "title": "Bal Pharma Stock Falls to 52-Week Low of Rs.74 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-stock-falls-to-52-week-low-of-rs74-amidst-continued-downtrend-3730581",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/BalPharma_priceRelatedfactors_3730581.png",
        "date": "2025-11-26 09:27:09",
        "description": "Bal Pharma has reached a new 52-week low of Rs.74, marking a significant decline as the stock continues its downward trajectory over the past eight trading sessions."
      },
      {
        "title": "Bal Pharma Stock Falls to 52-Week Low of Rs.74 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-stock-hits-52-week-low-at-rs74-amidst-continued-downtrend-3730578",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/BalPharma_priceRelatedfactors_3730578.png",
        "date": "2025-11-26 09:27:07",
        "description": "Bal Pharma has reached a new 52-week low of Rs.74, marking a significant decline as the stock continues its downward trajectory over the past eight trading sessions. This fresh low reflects ongoing pressures within the Pharmaceuticals & Biotechnology sector and highlights the challenges faced by the company in recent periods."
      },
      {
        "title": "Bal Pharma Stock Falls to 52-Week Low of Rs.74.2 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-stock-falls-to-52-week-low-of-rs742-amidst-continued-downtrend-3729266",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/BalPharma_priceRelatedfactors_3729266.png",
        "date": "2025-11-25 15:40:01",
        "description": "Bal Pharma has reached a new 52-week low of Rs.74.2 today, marking a significant decline amid a sustained downward trajectory over the past week. The stock’s performance contrasts sharply with broader market trends, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Why is Bal Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-bal-pharma-fallingrising-3726729",
        "imagepath": "",
        "date": "2025-11-25 00:46:58",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Persistent Downward Momentum</strong></p>\n<p>Bal Pharma’s recent price action reflects a challenging period for the company’s stock. Over the past week, the share price has fallen by 6.45%, significantly underperforming the Sensex, which remained almost flat with a marginal decline of 0.06%. The one-month performance further emphasises this weakness, with the stock declining by 10.59%, while the Sensex gained 0.82% during the same period. This divergence highlights the stock’s relative underperformance against the benchmark index.</p>\n<p>Year-to-date figures paint an even more concerning picture. Bal Pharma has lost 38.98% of its value, contrasting sharply with the Sensex’s robust 8.65% gain. Over the last twelve months, the stock’s decline deepens to 44.96%, while the Sensex has appreciated..."
      },
      {
        "title": "Bal Pharma Stock Falls to 52-Week Low of Rs.75 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-stock-falls-to-52-week-low-of-rs75-amidst-continued-downtrend-3724732",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/BalPharma_priceRelatedfactors_3724732.png",
        "date": "2025-11-24 10:41:37",
        "description": "Bal Pharma has reached a new 52-week low of Rs.75 today, marking a significant decline amid a sustained period of negative returns and underperformance relative to its sector and benchmark indices."
      }
    ],
    "total": 109,
    "sid": "555664",
    "stock_news_url": "https://www.marketsmojo.com/news/bal-pharma-555664"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "17-Nov-2025",
      "details": "We are submitting to the exchanges news paper advertisements of the unaudited standalone and consolidated financial results of the company for the quarter ended 30.09.2029 announced by the company on 12.11.2025 and published in financial express and Sanjayvani on 14.11.2025.",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Financial Results For The Quarter Ended 30.09.2025",
      "datetime": "12-Nov-2025",
      "details": "Unaudited standalone and Consolidated financial results for the quarter ended 30.09.2025.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting_12.11.2025",
      "datetime": "12-Nov-2025",
      "details": "Board of Directors of the Company has inter alia 1. Approved the unaudited standalone and consolidate financial results for the quarter ended 30.09.2025. 2. Appointed Dr.B.Mukesh ( DIN # 11295580)as additional Director of the Company.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bal Pharma Ltd has declared <strong>12%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Bal Pharma’s Market Assessment Revised Amidst Challenging Financial and Technical Indicators

2025-12-05 10:10:27

Bal Pharma has experienced a revision in its market evaluation, reflecting a more cautious outlook driven by recent financial results, valuation considerations, and technical trends. This shift highlights the complexities facing the pharmaceutical company amid ongoing sector challenges and market pressures.

Read More

Bal Pharma Stock Falls to 52-Week Low of Rs.73.04 Amidst Prolonged Downtrend

2025-12-05 09:53:08

Bal Pharma's shares touched a fresh 52-week low of Rs.73.04 today, marking a significant milestone in the stock's ongoing downward trajectory. This new low reflects continued pressures on the company’s financial performance and market valuation within the Pharmaceuticals & Biotechnology sector.

Read More

Bal Pharma Stock Falls to 52-Week Low of Rs.73.04 Amidst Prolonged Downtrend

2025-12-05 09:53:08

Bal Pharma’s shares touched a fresh 52-week low of Rs.73.04 today, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s stock declined by 2.05% during the trading session, underperforming its sector peers and continuing a trend of subdued market performance over the past year.

Read More

Bal Pharma Stock Falls to 52-Week Low of Rs.73.61 Amidst Prolonged Downtrend

2025-12-04 12:43:48

Bal Pharma's shares reached a fresh 52-week low of Rs.73.61 today, marking a continuation of the stock's downward trajectory over recent sessions. The pharmaceutical company’s stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial and operational metrics.

Read More

Bal Pharma Stock Falls to 52-Week Low of Rs.74 Amidst Prolonged Downtrend

2025-11-26 09:27:09

Bal Pharma has reached a new 52-week low of Rs.74, marking a significant decline as the stock continues its downward trajectory over the past eight trading sessions.

Read More

Bal Pharma Stock Falls to 52-Week Low of Rs.74 Amidst Prolonged Downtrend

2025-11-26 09:27:07

Bal Pharma has reached a new 52-week low of Rs.74, marking a significant decline as the stock continues its downward trajectory over the past eight trading sessions. This fresh low reflects ongoing pressures within the Pharmaceuticals & Biotechnology sector and highlights the challenges faced by the company in recent periods.

Read More

Bal Pharma Stock Falls to 52-Week Low of Rs.74.2 Amidst Prolonged Downtrend

2025-11-25 15:40:01

Bal Pharma has reached a new 52-week low of Rs.74.2 today, marking a significant decline amid a sustained downward trajectory over the past week. The stock’s performance contrasts sharply with broader market trends, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.

Read More

Why is Bal Pharma falling/rising?

2025-11-25 00:46:58

Persistent Downward Momentum

Bal Pharma’s recent price action reflects a challenging period for the company’s stock. Over the past week, the share price has fallen by 6.45%, significantly underperforming the Sensex, which remained almost flat with a marginal decline of 0.06%. The one-month performance further emphasises this weakness, with the stock declining by 10.59%, while the Sensex gained 0.82% during the same period. This divergence highlights the stock’s relative underperformance against the benchmark index.

Year-to-date figures paint an even more concerning picture. Bal Pharma has lost 38.98% of its value, contrasting sharply with the Sensex’s robust 8.65% gain. Over the last twelve months, the stock’s decline deepens to 44.96%, while the Sensex has appreciated...

Read More

Bal Pharma Stock Falls to 52-Week Low of Rs.75 Amidst Prolonged Downtrend

2025-11-24 10:41:37

Bal Pharma has reached a new 52-week low of Rs.75 today, marking a significant decline amid a sustained period of negative returns and underperformance relative to its sector and benchmark indices.

Read More

View All News